Study on Chinese and Western Medicine in MNE Children
Sadece kayıtlı kullanıcılar makaleleri çevirebilir
Giriş yapmak kayıt olmak
Bağlantı panoya kaydedilir
Durumİşe alma
Sponsorlar
Children's Hospital of Fudan University
KLINIK ÇALIŞMA: NCT03733873
BioSeek: nct03733873
Anahtar kelimeler
Öz
Monosymptomatic nocturnal enuresis (MNE) is a common pediatric developmental disorder. MNE refers to urinary incontinence in the sleep state in children aged ≥5 years, without other LUT symptoms, and without bladder dysfunction. Its pathogenesis mainly include overnight polyuria, overactive bladder, sleep-arousal dysfunction, genetics, and abnormal secretion of anti-diuretic hormone (ADH). Desmopressin is a synthetic analog of ADH arginine-vasopressin (AVP), which is used to treat central diabetes insipidus and primary nocturnal enuresis (PNE). Desmopressin decreases urine production at night when taken at bedtime. Insufficient ADH secretion at night will contribute to nocturnal polyuria, which is an important cause of NE. Therefore, desmopressin, a synthetic analog of ADH, is frequently used for NE and is an evidence-based therapy (grade ⅠA evidence). Some children, however, have desmopressin resistance and do not achieve the desired treatment goals. What's more,there's a high relapse rate of desmopressin after withdrawing. Suoquan mixture is a Chinese medicine commonly used to treat NE in children. It is composed of Cuscuta, Codonopsis, Psoralea corylifolia Linn ,Astragalus,mantis egg-case and ephedra. It has not only a certain cure rate but also has a lower relapse rate . However there's few evidence could prove that. In this study,the investigators compared the 3 month treatment response and relapse rate (RR) in the following 6 months of desmopressin and desmopressin plus suoquan, and observe if there will be a lower relapse rare in desmopressin plus Suoquan. Moreover, the investigators will try to explore the mechanism of Suoquan mixture in MNE.
Tarih
Son Doğrulandı: | 10/31/2019 |
İlk Gönderilen: | 11/05/2018 |
Tahmini Kayıt Gönderildi: | 11/05/2018 |
İlk Gönderilen: | 11/06/2018 |
Son Güncelleme Gönderildi: | 11/07/2019 |
Son Güncelleme Gönderildi: | 11/11/2019 |
Fiili Çalışma Başlangıç Tarihi: | 02/13/2019 |
Tahmini Birincil Tamamlanma Tarihi: | 10/31/2020 |
Tahmini Çalışma Tamamlanma Tarihi: | 11/30/2020 |
Durum veya hastalık
Monosymptomatic Nocturnal Enuresis
Müdahale / tedavi
Drug: Desmopressin
Drug: desmopressin plus Suoquan
Evre
-
Kol Grupları
Kol | Müdahale / tedavi |
---|---|
Experimental: desmopressin plus Suoquan Drug1. name:desmopressin form:tablet dosage:2-4mg frequency:qn duration:3 months Drug2 name:Suoquan mixture form:liquid dosage:10ml/time frequence:bid duration:3 months | Drug: desmopressin plus Suoquan take Suoquan mixture for 3 months |
Active Comparator: desmopressin name:desmopressin form:tablet dosage:2-4mg frequency:qn duration:3 months |
Uygunluk kriterleri
Çalışmaya Uygun Yaşlar | 5 Years İçin 5 Years |
Çalışmaya Uygun Cinsiyetler | All |
Sağlıklı Gönüllüleri Kabul Ediyor | Evet |
Kriterler | Inclusion Criteria: - bedwetting occured ≥2nights/week,last for at least 3 months - without other LUT symptoms - without bladder dysfunction. - no treatment in last 3 months - signed the consent Exclusion Criteria: - had other LUT symptoms - with bladder dysfunction - had treatment in last 3 months - without the consent |
Sonuç
Birincil Sonuç Ölçütleri
1. the relapse rate of MNE [in 6 months after stopping drugs]
If Suoquan mixture plus desmopressin could reduce the relapse rate of MNE